Seeking Alpha

Bristol-Myers Squibb (BMY) launches its $31/share tender offer to buy Amylin Pharmaceuticals...

Bristol-Myers Squibb (BMY) launches its $31/share tender offer to buy Amylin Pharmaceuticals (AMLN) in a deal that will extend BMY's portfolio of diabetes treatments. The offer will expire on Aug. 7.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|